A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,090

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions
Vivax Malaria
Interventions
DRUG

Tafenoquine

oral treatment

DRUG

Primaquine

oral treatment

Trial Locations (4)

Unknown

RECRUITING

Dr Marcus Lacerda, Manaus

RECRUITING

Arba Minch General Hospital, Arba Minch

NOT_YET_RECRUITING

Puskesmas Hanura, Hanura

RECRUITING

Dr Moses Laman and Dr Brioni Moore, Alexishafen

All Listed Sponsors
collaborator

University of Melbourne

OTHER

collaborator

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado

OTHER

collaborator

Arba Minch University

OTHER

collaborator

Addis Ababa University

OTHER

collaborator

Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Indonesia

UNKNOWN

collaborator

Curtin University

OTHER

collaborator

Papua New Guinea Institute of Medical Research

OTHER_GOV

lead

Menzies School of Health Research

OTHER